Citigroup’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-100
| Closed | – | – | 5304 |
|
2019
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 5329 |
|
2018
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 5281 |
|
2018
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 5294 |
|
2018
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 5255 |
|
2018
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 5183 |
|
2017
Q4 | $0 | Sell |
100
-1,604
| -94% | – | ﹤0.01% | 5159 |
|
2017
Q3 | $7K | Buy |
1,704
+34
| +2% | +$140 | ﹤0.01% | 4300 |
|
2017
Q2 | $5K | Buy |
1,670
+936
| +128% | +$2.8K | ﹤0.01% | 4356 |
|
2017
Q1 | $7K | Buy |
734
+134
| +22% | +$1.28K | ﹤0.01% | 4413 |
|
2016
Q4 | $5K | Sell |
600
-250
| -29% | -$2.08K | ﹤0.01% | 4682 |
|
2016
Q3 | $10K | Sell |
850
-2,744
| -76% | -$32.3K | ﹤0.01% | 4468 |
|
2016
Q2 | $45K | Sell |
3,594
-11,420
| -76% | -$143K | ﹤0.01% | 3755 |
|
2016
Q1 | $152K | Buy |
15,014
+2,044
| +16% | +$20.7K | ﹤0.01% | 3690 |
|
2015
Q4 | $292K | Buy |
12,970
+6,218
| +92% | +$140K | ﹤0.01% | 2769 |
|
2015
Q3 | $112K | Sell |
6,752
-6,973
| -51% | -$116K | ﹤0.01% | 3114 |
|
2015
Q2 | $309K | Sell |
13,725
-521
| -4% | -$11.7K | ﹤0.01% | 2468 |
|
2015
Q1 | $367K | Sell |
14,246
-5,713
| -29% | -$147K | ﹤0.01% | 2514 |
|
2014
Q4 | $435K | Buy |
19,959
+10,670
| +115% | +$233K | ﹤0.01% | 2557 |
|
2014
Q3 | $176K | Buy |
9,289
+254
| +3% | +$4.81K | ﹤0.01% | 2742 |
|
2014
Q2 | $211K | Buy |
9,035
+6,066
| +204% | +$142K | ﹤0.01% | 2540 |
|
2014
Q1 | $100K | Sell |
2,969
-1,273
| -30% | -$42.9K | ﹤0.01% | 3489 |
|
2013
Q4 | $125K | Buy |
+4,242
| New | +$125K | ﹤0.01% | 3536 |
|